Search research articles
Contact Us
Filters
Showing results (181-190 of 198) with videos related to
Page
of 20
Sort By:
ESMO Open
|
September 6, 2024
High-dose chemotherapy with autologous stem cell transplants in adult primary non-seminoma mediastinal germ-cell tumors. A report from the Cellular Therapy and Immunobiology working party of the EBMT
S Secondino, M Badoglio, G Rosti, et al.
Leukemia
|
April 29, 2016
European LeukemiaNet recommendations for the management and avoidance of adverse events of treatment in chronic myeloid leukaemia
J L Steegmann, M Baccarani, M Breccia, et al.
British Journal of Haematology
|
August 8, 1998
Unrelated donor marrow transplantation for chronic myelogenous leukaemia
G Dini, T Lamparelli, R Rondelli, et al.
Bone Marrow Transplantation
|
January 1, 1996
Unrelated donor marrow transplantation: initial experience of the Italian bone marrow transplant group (GITMO)
G Dini, E Lanino, T Lamparelli, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 8, 2014
Personalizing, not patronizing: the case for patient autonomy by unbiased presentation of management options in stage I testicular cancer
J Oldenburg, J Aparicio, J Beyer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 2, 2014
Differences among young adults, adults and elderly chronic myeloid leukemia patients
F Castagnetti, G Gugliotta, M Baccarani, et al.
Leukemia
|
June 20, 2015
Long-term outcome of chronic myeloid leukemia patients treated frontline with imatinib
F Castagnetti, G Gugliotta, M Breccia, et al.
Leukemia
|
June 4, 2010
Nilotinib is active in chronic and accelerated phase chronic myeloid leukemia following failure of imatinib and dasatinib therapy
F J Giles, E Abruzzese, G Rosti, et al.
Leukemia
|
February 19, 2013
Chronic fatigue is the most important factor limiting health-related quality of life of chronic myeloid leukemia patients treated with imatinib
F Efficace, M Baccarani, M Breccia, et al.
Blood
|
November 8, 2001
Chronic myeloid leukemia and interferon-alpha: a study of complete cytogenetic responders
F Bonifazi, A de Vivo, G Rosti, et al.
Page
of 20
Search research articles
Search
Showing results (181-190 of 198) with videos related to
Sort By:
Page
of 20
ESMO Open
|
September 6, 2024
High-dose chemotherapy with autologous stem cell transplants in adult primary non-seminoma mediastinal germ-cell tumors. A report from the Cellular Therapy and Immunobiology working party of the EBMT
S Secondino, M Badoglio, G Rosti, et al.
Leukemia
|
April 29, 2016
European LeukemiaNet recommendations for the management and avoidance of adverse events of treatment in chronic myeloid leukaemia
J L Steegmann, M Baccarani, M Breccia, et al.
British Journal of Haematology
|
August 8, 1998
Unrelated donor marrow transplantation for chronic myelogenous leukaemia
G Dini, T Lamparelli, R Rondelli, et al.
Bone Marrow Transplantation
|
January 1, 1996
Unrelated donor marrow transplantation: initial experience of the Italian bone marrow transplant group (GITMO)
G Dini, E Lanino, T Lamparelli, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 8, 2014
Personalizing, not patronizing: the case for patient autonomy by unbiased presentation of management options in stage I testicular cancer
J Oldenburg, J Aparicio, J Beyer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 2, 2014
Differences among young adults, adults and elderly chronic myeloid leukemia patients
F Castagnetti, G Gugliotta, M Baccarani, et al.
Leukemia
|
June 20, 2015
Long-term outcome of chronic myeloid leukemia patients treated frontline with imatinib
F Castagnetti, G Gugliotta, M Breccia, et al.
Leukemia
|
June 4, 2010
Nilotinib is active in chronic and accelerated phase chronic myeloid leukemia following failure of imatinib and dasatinib therapy
F J Giles, E Abruzzese, G Rosti, et al.
Leukemia
|
February 19, 2013
Chronic fatigue is the most important factor limiting health-related quality of life of chronic myeloid leukemia patients treated with imatinib
F Efficace, M Baccarani, M Breccia, et al.
Blood
|
November 8, 2001
Chronic myeloid leukemia and interferon-alpha: a study of complete cytogenetic responders
F Bonifazi, A de Vivo, G Rosti, et al.
Page
of 20